Crafted with ingenuity to build a benchmark intelligent factory in the peptide industry, unlocking new possibilities for biological activity

In today's rapidly developing biotechnology, peptides have become the core raw materials in fields such as medicine, beauty, and health food due to their unique advantages of high activity and easy absorption. Behind all of this value lies the hardcore technology support and lean production capabilities of peptide factories. As the core carrier of the peptide industry, modern peptide factories are using innovative technology to reconstruct industry standards and deliver high-quality peptide products to the global market.

The core competitiveness of high-quality peptide factories begins with technological breakthroughs. By adopting a combination of solid-phase synthesis and liquid-phase synthesis processes, the advantages of solid-phase synthesis automation and high-throughput are fully utilized, while liquid-phase synthesis ensures high purity of long-chain peptides and complex modified peptides, achieving full category coverage from short peptides to long peptides. Equipped with a fully automated intelligent production line, the modular design enables rapid switching between multiple products, resulting in a 30% increase in production efficiency compared to traditional processes. The product qualification rate remains stable at over 99.8%, and the entire process from raw material processing to finished product purification is controllable. At the same time, relying on HPLC efficient purification technology and mass spectrometry detection methods, the purity of the product is ensured to be over 99%, and the proportion of ultrafine peptide segments is ≥ 99.99%, meeting the diverse needs of pharmaceutical grade, food grade and other scenarios.

In terms of quality control, the peptide factory adheres to strict standards. We carefully select natural sources such as North Atlantic deep-sea cod skin and high-quality plant protein, establish a full traceability system, and eliminate impurities and pollutant residues. The production environment follows the 100000 level clean room standard, and the low-temperature enzymatic hydrolysis process retains more than 98% of the biological activity of the peptide segment. The residual heavy metal is controlled below 0.1mg/kg, which meets multiple authoritative certification requirements at home and abroad. Through deep cooperation between industry, academia, and research, we aim to establish a comprehensive R&D system covering peptide sequence design, synthesis optimization, and efficacy verification, and continuously launch functional peptide products that are suitable for different scenarios.

Today, the products produced by these peptide factories have been widely used in the fields of diabetes treatment drugs, anti-aging skin care products, immunomodulatory health care products, etc., injecting strong impetus into the development of the health industry. From laboratory technological breakthroughs to industrial scale production, modern peptide factories are unlocking infinite possibilities for bioactive peptides with ingenuity and technology, steadily advancing the peptide industry towards high quality and internationalization.